Quang X. Pham, CEO and Chairman, 10% Owner at Cadrenal Therapeutics, Inc. (CVKD), sold 12,763 shares at $5.76 ($69K) on 2026-05-11, disclosed to the SEC on 2026-05-29.
Scheduled sale ($69k) by CEO and Chairman, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.76 | 6,476 | $37K | 53.7% |
| 2 | $5.28 | 3,298 | $17K | 25.1% |
| 3 | $4.93 | 2,989 | $15K | 21.2% |
| Total | $5.44 avg | 12,763 | $69K | 100% |
| Filing → |
| CVKD | SELL | 2026-06-24 | $40K | — | Filing → |
| CVKD | SELL | 2026-06-18 | $13K | — | Filing → |
| CVKD | SELL | 2026-06-15 | $70K | — | Filing → |